Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) EBIT: R$-2,895 Mil (TTM As of Mar. 2026)


BSP:ONCO3 Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
43 GF Score
Price R$1.09
GF Value R$3.49
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Oncoclinicas Do Brasil Servicos Medicos EBIT?

Oncoclinicas Do Brasil Servicos Medicos BSP:ONCO3 -11.38% 43 EBIT is R$-2,895 Mil as of Mar. 2026. GuruFocus rates BSP:ONCO3 with a GF Score™ of 43/100 and a GF Value™ of R$3.49 (Possible Value Trap). The stock has 6 warning signs investors should review.

Oncoclinicas Do Brasil Servicos Medicos's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was R$-303 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was R$-2,895 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Oncoclinicas Do Brasil Servicos Medicos's annualized ROC % for the quarter that ended in Mar. 2026 was -14.57%. Oncoclinicas Do Brasil Servicos Medicos's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -59.34%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Oncoclinicas Do Brasil Servicos Medicos's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -57.46%.


Oncoclinicas Do Brasil Servicos Medicos  (BSP:ONCO3) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Oncoclinicas Do Brasil Servicos Medicos's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-1164.66 * ( 1 - 0% )/( (7967.582 + 8016.83)/ 2 )
=-1164.66/7992.206
=-14.57 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7130.514 - 1468.642 - ( 510.285 - max(0, 5201.94 - 2896.23+510.285))
=7967.582

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6699.638 - 1563.2 - ( 112.287 - max(0, 5350.118 - 2469.726+112.287))
=8016.83

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Oncoclinicas Do Brasil Servicos Medicos's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1212.616/( ( (1102.606 + max(952.08, 0)) + (1077.223 + max(955.424, 0)) )/ 2 )
=-1212.616/( ( 2054.686 + 2032.647 )/ 2 )
=-1212.616/2043.6665
=-59.34 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2033.56 + 185.477 + 710.484) - (1468.642 + 0 + 508.799)
=952.08

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2028.736 + 136.384 + 758.79) - (1563.2 + 0 + 405.286)
=955.424

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Oncoclinicas Do Brasil Servicos Medicos's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-2895.137/5038.543
=-57.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncoclinicas Do Brasil Servicos Medicos EBIT Related Terms


Oncoclinicas Do Brasil Servicos Medicos EBIT Historical Data

* Premium members only.

The historical data trend for Oncoclinicas Do Brasil Servicos Medicos's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncoclinicas Do Brasil Servicos Medicos EBIT Chart

Oncoclinicas Do Brasil Servicos Medicos Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 216.70 518.01 862.31 -55.14 -2,526.37

Oncoclinicas Do Brasil Servicos Medicos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.62 33.48 -1,681.97 -943.49 -303.15

BSP:ONCO3 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Oncoclinicas Do Brasil Servicos Medicos's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncoclinicas Do Brasil Servicos Medicos EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oncoclinicas Do Brasil Servicos Medicos's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Oncoclinicas Do Brasil Servicos Medicos's EV-to-EBIT falls into.


BSP:ONCO3
43GF Score
Oncoclinicas Do Brasil Servicos Medicos SA BSP:ONCO3
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncoclinicas Do Brasil Servicos Medicos EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-2,895 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of R$-2,895 Mil mean?
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) has a EBIT of R$-2,895 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Oncoclinicas Do Brasil Servicos Medicos.
Is Oncoclinicas Do Brasil Servicos Medicos' EBIT too high?
Oncoclinicas Do Brasil Servicos Medicos' current EBIT is R$-2,895 Mil. Overall, Oncoclinicas Do Brasil Servicos Medicos has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oncoclinicas Do Brasil Servicos Medicos' EBIT compare to HCA and THC?
Oncoclinicas Do Brasil Servicos Medicos' EBIT of R$-2,895 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Oncoclinicas Do Brasil Servicos Medicos. Oncoclinicas Do Brasil Servicos Medicos's current EBIT is R$-2,895 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoclinicas Do Brasil Servicos Medicos stock overvalued right now?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$3.49, compared to a current price of R$1.09 — trading 68.8% below its estimated fair value. The current EBIT is R$-2,895 Mil. Oncoclinicas Do Brasil Servicos Medicos' overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3), the current EBIT is R$-2,895 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Overvalued in 2026?

Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos stock appears to be undervalued. The current stock price of R$1.09 is trading 68.8% below its estimated GF Value™ of R$3.49. GuruFocus considers Oncoclinicas Do Brasil Servicos Medicos to be Possible Value Trap.

Key valuation signals for BSP:ONCO3:

  • EBIT: R$-2,895 Mil
  • GF Value™: R$3.49 vs. price of R$1.09 (68.8% below fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the BSP:ONCO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oncoclinicas Do Brasil Servicos Medicos Business Description

Address Avenida Presidente Juscelino Kubitschek, No. 510, 2nd Floor, Vila Nova Conceicao, Sao Paulo, SP, BRA, 04543-906
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.
43GF Score

Get the complete analysis for BSP:ONCO3

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$1.09
Price
R$3.49
GF Value